Cross-national cognitive assessment in schizophrenia clinical trials: a feasibility study (Q43708806)

26 November 2017

title

Cross-national cognitive assessment in schizophrenia clinical trials: a feasibility study (English)

1 reference

26 November 2017

0 references

1 reference

Philip D Harvey

1

1 reference

26 November 2017

Lidia Artiola i Fortuny

series ordinal

2

1 reference

26 November 2017

Estelle Vester-Blockland

series ordinal

3

1 reference

26 November 2017

Goedele De Smedt

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

26 November 2017

published in

Schizophrenia Research

1 reference

26 November 2017

volume

59

1 reference

26 November 2017

issue

2-3

1 reference

26 November 2017

page(s)

243-251

1 reference

Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900153-6

7 January 2021

The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900153-6

7 January 2021

The Paced Auditory Serial Addition Task (PASAT): norms for age, education, and ethnicity

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900153-6

7 January 2021

Use of oral reading to estimate premorbid intellectual and neuropsychological functioning

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900153-6

7 January 2021

Norms for letter and category fluency: demographic corrections for age, education, and ethnicity

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900153-6

7 January 2021

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900153-6

7 January 2021

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900153-6

7 January 2021

Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900153-6

7 January 2021

Further crossvalidation of regression-based neuropsychological norms with an update for the Boston Naming Test

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900153-6

7 January 2021

Demographically corrected norms for the California Verbal Learning Test

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900153-6

7 January 2021

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900153-6

7 January 2021

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2802%2900153-6

7 January 2021

10.1016/S0920-9964(02)00153-6

Identifiers

DOI

1 reference

release_7y42lxn7brfvphdccuhdpxsvdi

26 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7y42lxn7brfvphdccuhdpxsvdi

24 November 2022

mapped directly with Wikidata item

1 reference